Official SUTENT® site—Steps to apply for First Resource® support

For Physicians | For Nurses

Medication Guide | Site Map | Full Prescribing Information

Home

About kidney cancer

SUTENT and kidney cancer

First Resource Support Services

Access to Pfizer medicines

Easy steps to apply

Get the enrollment form

Tools for patients

Tools for caregivers

Education and support

Important safety information

Get e-mail updates

Treating GIST with SUTENT

Treating pancreatic NET with SUTENT

E-mail this page to a friend

Printer-friendly page

Back

SUTENT is used to treat advanced kidney cancer (advanced renal cell carcinoma or RCC).

To apply for any First Resource program, call 1-877-744-5675. Once a First Resource counselor determines your needs and eligibility,* you will need to complete an enrollment form. Your eligibility can be determined over the phone and an initial supply of SUTENT will be sent to your physician or provider. The complete enrollment form can be faxed or mailed to First Resource.

The following patient information is required for the application:

Name and address
Date of birth
Household size and monthly income*
Insurance information
Doctor’s name

When you apply, you can mail completed enrollment form to:
Pfizer First Resource
PO Box 220582
Charlotte, NC 28222-0582

You may also fax it to 1-800-708-3430.

First Resource is a part of the Pfizer Helpful Answers^® family of patient assistance programs—a joint program of Pfizer Inc and the Pfizer Patient Assistance Foundation™.

Proof of income, which is required within 30 days of enrollment, includes items such as your most recent federal income tax return, W-2 form(s), Social Security check, or a copy of their most recent pay stub. Patient eligibility can be determined over the phone, and an initial supply of medicine will be sent to your physician or provider.

NEXT: Get the enrollment form

Pfizer and its agents cannot guarantee the accuracy of information provided by insurers, nor do they guarantee insurance reimbursement. Because many factors influence reimbursement, program staff cannot anticipate or resolve all issues raised by program callers. Pfizer reserves the right to modify or discontinue the program, without notice, at any time.

SUTENT is a prescription medicine used to treat people with:

a rare cancer of the stomach, bowel, or esophagus called GIST (gastrointestinal stromal tumor) and when:

the medicine Gleevec^® (imatinib mesylate) did not stop the cancer from growing, or
you cannot take Gleevec^®

advanced kidney cancer (advanced renal cell carcinoma or RCC)
a type of pancreatic cancer known as pancreatic neuroendocrine tumors (pNET), that has progressed and cannot be treated with surgery

Important Safety Information
SUTENT can cause serious liver problems, including death.
Tell your healthcare provider right away if you develop any of the following during treatment with SUTENT: itching; yellow eyes or skin; dark urine; or pain or discomfort in the right upper stomach area.

Your healthcare provider should do blood tests to check your liver function before you start taking SUTENT and during treatment.

SUTENT may cause heart problems that can lead to death. Heart problems may include heart failure, heart muscle problems (cardiomyopathy) or abnormal heart rhythm changes. Tell your healthcare provider if you feel dizzy, faint, very tired, have abnormal heartbeats, are short of breath, or have swollen feet and ankles while taking SUTENT.

SUTENT may cause high blood pressure. Your healthcare provider may check your blood pressure, and may treat you for high blood pressure.

SUTENT may cause bleeding sometimes leading to death. Tell your healthcare provider right away if you have any of the following during treatment with SUTENT: serious bleeding; painful swollen stomach (abdomen); vomiting blood; black sticky stools; bloody urine; headache or change in your mental status.

SUTENT may cause hormone problems, including thyroid and adrenal gland problems. Your healthcare provider may do tests to check your thyroid and adrenal gland function during SUTENT treatment.

SUTENT may harm an unborn baby (cause birth defects). Do not become pregnant. If you do, tell your healthcare provider right away. Stop taking SUTENT. Do not breastfeed while taking SUTENT.

Using SUTENT with other medicines can cause serious side effects. Tell your healthcare provider about all the medicines, vitamins, or herbal products you use.

You may have side effects or reactions to SUTENT. For most patients, these are moderate and may be managed, though some can be serious. Your healthcare provider may change your dose or stop your treatment. Some of the most common side effects include tiredness, weakness, fever, diarrhea, nausea, vomiting, mouth sores, upset stomach, abdominal pain, constipation, skin or hair changes, taste changes, swelling, loss of appetite, and bleeding, such as from the nose or cuts. Tell your healthcare provider if you have any swelling or bleeding. Be sure to tell your healthcare provider about any new side effects you have, as well as any change or increase in any side effect.

Gleevec is a registered trademark of Novartis AG.

Please see patient Medication Guide and full prescribing information.

Pfizer is a licensee of the TRUSTe Privacy Program.

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider. All decisions regarding patient care must be made with a health care provider, considering the unique characteristics of the patient.

This product information provided in this site is intended only for residents of the United States. The products discussed herein may have different labeling in different countries.